Cannabidiol News March 22 2019
several challenges in care particularly with higher numbers of coexisting conditions and related polypharmacy.
Pharmaceutically Manufactured CBD Cardiol Therapeutics Inc. (TSX:CRDL)
- Implementing nanotechnologies to deliver CBD and other anti-inflammatory drugs for the treatment of diastolic heart failure.
- Commercializing one of the most advanced formulations of pharmaceutical cannabidiol at >99.5% purity and less than 10 ppm THC during 2019 – a market estimated to exceed $600 million in Canada alone.
- Research programs at the University of Alberta, the Houston Methodist DeBakey Heart & Vascular Center, and TecSalud del Tecnológico de Monterrey, Mexico.
- Developing a combination therapy of cannabinoids and cell-based immunotherapies to improve the treatment of GBM.
- Exclusive partnerships with Dalton Pharma Services and Noramco.
- Management holds approximately 35 percent of the Company’s shares.
In collaboration with Dalton Pharma Services, Cardiol is developing unique manufacturing expertise in the production of pharmaceutical cannabinoids in support of its nanotherapeutics program in heart failure. With the de-scheduling of cannabinoids from the federal Controlled Drugs and Substances Act, the Company believes there is a significant opportunity to manufacture and commercialize pure pharmaceutical cannabidiol regulated by the federal Cannabis Act. Cardiol is developing cannabidiol products that are >99.5 purity and TCH free (less than 10 ppm). The Company plans to introduce a cannabidiol oil product in 2019 and in H2, 2019 a water-like cannabidiol in a sublingual spray for ease of administration. 30 years of experience.
The Industrial Hemp Revolution is here with the power to transform Southern Oregon’s economy and revive family farms and small businesses.
SATURDAY, MARCH 23, join the CEO of Hemp, Inc. and Hemp Activist Bruce Perlowin and his team of local and international experts in Industrial Hemp at Southern Oregon University for a full day of EDUCATION, NETWORKING and SUPPORT for Hemp Growers and Entrepreneurs. At the Stevenson Union Building, Arena Room. Registration 8:15 AM
EIGHT MASTER CLASSES and Networking Activities from 9 AM to 7 PM.
Lunch and Coffee Break included.
info & details : Please email HempU@HempInc.com for a copy of the schedule or simply visit our website
www.thehempuniversity.com for details on all our great Speakers and Master Classes.
GLEN ALLEN, Va., March 11, 2019 (GLOBE NEWSWIRE) — This release corrects and replaces the version issued this morning at 6:30 AM ET. The complete and corrected release follows:
Exactus Inc. (OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has acquired a majority interest in a 200 acre industrial hemp farm located in Cave Junction, Oregon.
Cave Junction, incorporated in 1948, is a city in Josephine County, Oregon, United States. As of the 2010 census, the city population was 1,883. Its motto is the “Gateway to the Oregon Caves”, and the city got its name by virtue of its location at the junction of Redwood Highway and Caves Highway.
Austin has a new CBD store, coffee shop, and bakery, serving CBD-infused baked goods and coffee with CBD drops. Flamingo Hemp is now open within downtown Austin music venue Flamingo Cantina at 515 East 6th Street. It opened right before SXSW on Wednesday, March 6.
The edibles, from local catering company Keep Austin Baked, are made with Flamingo’s own CBD-infused coconut oil. There are muffins, scones, chocolate chip cookies, gingerbread lollipops, chocolate-covered espresso bean clusters, etc., all infused with between ten to 25 milligrams of CBD per serving. There’s also a coffee menu with drip, espresso and iced coffees with optional CBD shots.
Lilu’s Garden is the first company to produce hemp derivatives at scale. Its developed a breakthrough patent pending Aqueous Extraction system that eliminates the need to remove water from hemp in advance of processing. This innovation makes it possible for Lilu’s to meet the surging demand for hemp derivatives.
Lilu’s Garden has created a vertical business that takes production from seed to derivative sale at a staggering scale. Able to process more than 300,000 lbs. of hemp biomass a day, Lilu’s operates a multi-faceted operation that is led by some of the industry’s brightest minds. Research & Development has been the driving force and allowing the company to expand and scale into all facets of the industry, including genetics, nationally scaled agricultural operations, hyper-efficient proprietary aqueous based processing and wholesale B2B distribution.
Lilu’s Garden anticipates to produce and sell approximately 450,000 kilograms of CBD and other minor cannabinoid from current hemp stock will be sold in 2019. The company is therefore increasing its production 10 fold by managing the farming of an unprecedented 75,000 acres of hemp production for the 2019 harvest, which will produce approximately 50,000,000 million lbs.+ of hemp and over 1,000,000 kilograms of Isolated CBD and other non-psychoactive cannabinoids to be sold in 2020.